Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N MEDEARIS

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Reviews of Infectious Diseases|September 1, 1990
Cell-mediated immunity in experimental cytomegalovirus infections: a perspectiveM S Pasternack, D N Medearis, R H Rubin
Clinical Immunology and Immunopathology|September 1, 1986
Changes in the phenotype of T-cell subset determinants following murine cytomegalovirus infectionD P Doody, E J Wilson, D N Medearis, et al.
Clinical Immunology and Immunopathology|April 1, 1986
The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunizationR H Rubin, E J Wilson, L V Barrett, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 1, 1992
Ethical dilemmas in child and adolescent consultation psychiatryJ Bloomberg, J Wozniak, N Fost, et al.
Transplantation|March 1, 1984
Primary cytomegalovirus infection following cardiac transplantation in a murine modelR H Rubin, E J Wilson, L V Barrett, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1987
9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c miceE J Wilson, D N Medearis, L A Hansen, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c miceR H Rubin, P Lynch, M S Pasternack, et al.
The American Journal of Pathology|August 1, 1986
Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infectionD L Gang, L V Barrett, E J Wilson, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
The in vivo and in vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infectionJ W van der Meer, R H Rubin, M Pasternack, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Reviews of Infectious Diseases|September 1, 1990
Cell-mediated immunity in experimental cytomegalovirus infections: a perspectiveM S Pasternack, D N Medearis, R H Rubin
Clinical Immunology and Immunopathology|September 1, 1986
Changes in the phenotype of T-cell subset determinants following murine cytomegalovirus infectionD P Doody, E J Wilson, D N Medearis, et al.
Clinical Immunology and Immunopathology|April 1, 1986
The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunizationR H Rubin, E J Wilson, L V Barrett, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 1, 1992
Ethical dilemmas in child and adolescent consultation psychiatryJ Bloomberg, J Wozniak, N Fost, et al.
Transplantation|March 1, 1984
Primary cytomegalovirus infection following cardiac transplantation in a murine modelR H Rubin, E J Wilson, L V Barrett, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1987
9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c miceE J Wilson, D N Medearis, L A Hansen, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1989
Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c miceR H Rubin, P Lynch, M S Pasternack, et al.
The American Journal of Pathology|August 1, 1986
Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infectionD L Gang, L V Barrett, E J Wilson, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
The in vivo and in vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infectionJ W van der Meer, R H Rubin, M Pasternack, et al.
Pageof 1